DocDollars

Astrazeneca Uk Limited

Great Britain (UK) · Reporting entity ID 100000010370

Total reported 2019–2025
$625.9M
#29 of 2,960 reporting companies — 0.8% of all reported industry payments
$75.9M in general payments across 13,566 records, plus $550.1M in research funding across 11,783 records.

How it breaks down

General payments $75,869,023
Research funding $550,063,027

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Astrazeneca Uk Limited reported $625.9M to US doctors and teaching hospitals from 2019 to 2025, ranking #29 of 2,960 reporting companies. 88% of that was research funding and 12% general payments such as consulting, speaking, food and travel. 13,566 general payment records and 11,783 research records were filed.

Common questions about Astrazeneca Uk Limited

How much has Astrazeneca Uk Limited paid US doctors?

Astrazeneca Uk Limited reported $625,932,050 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $75,869,023 in general payments, $550,063,027 in research funding.

How does Astrazeneca Uk Limited rank among drug and device companies?

It ranks #29 of 2,960 reporting entities by total reported value, about 0.8% of all industry payments in the dataset.

Does a payment from Astrazeneca Uk Limited mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.